These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1625205)

  • 1. Modulation by certain conserved aspartate residues of the allosteric interaction of gallamine at the m1 muscarinic receptor.
    Lee NH; Hu J; el-Fakahany EE
    J Pharmacol Exp Ther; 1992 Jul; 262(1):312-6. PubMed ID: 1625205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of acidic amino acids in the allosteric modulation by gallamine of antagonist binding at the m2 muscarinic acetylcholine receptor.
    Leppik RA; Miller RC; Eck M; Paquet JL
    Mol Pharmacol; 1994 May; 45(5):983-90. PubMed ID: 8190113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allosteric interactions at the m1, m2 and m3 muscarinic receptor subtypes.
    Lee NH; el-Fakahany EE
    J Pharmacol Exp Ther; 1991 Feb; 256(2):468-79. PubMed ID: 1993991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probing of the location of the allosteric site on m1 muscarinic receptors by site-directed mutagenesis.
    Matsui H; Lazareno S; Birdsall NJ
    Mol Pharmacol; 1995 Jan; 47(1):88-98. PubMed ID: 7838137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alanine scanning mutagenesis of conserved arginine/lysine-arginine/lysine-X-X-arginine/lysine G protein-activating motifs on m1 muscarinic acetylcholine receptors.
    Lee NH; Geoghagen NS; Cheng E; Cline RT; Fraser CM
    Mol Pharmacol; 1996 Jul; 50(1):140-8. PubMed ID: 8700106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes of cooperativity between N-methylscopolamine and allosteric modulators alcuronium and gallamine induced by mutations of external loops of muscarinic M(3) receptors.
    Krejcí A; Tucek S
    Mol Pharmacol; 2001 Oct; 60(4):761-7. PubMed ID: 11562438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complex allosteric modulation of cardiac muscarinic receptors by protamine: potential model for putative endogenous ligands.
    Hu J; Wang SZ; Forray C; el-Fakahany EE
    Mol Pharmacol; 1992 Aug; 42(2):311-21. PubMed ID: 1513329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of two highly conserved tyrosine residues in the m1 muscarinic receptor second transmembrane domain in ligand binding and receptor function.
    Lee SY; Zhu SZ; el-Fakahany EE
    Recept Signal Transduct; 1996; 6(1):43-52. PubMed ID: 8933621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Competition between positive and negative allosteric effectors on muscarinic receptors.
    Proska J; Tucek S
    Mol Pharmacol; 1995 Oct; 48(4):696-702. PubMed ID: 7476896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subtype selectivity of the positive allosteric action of alcuronium at cloned M1-M5 muscarinic acetylcholine receptors.
    Jakubík J; Bacáková L; el-Fakahany EE; Tucek S
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1077-83. PubMed ID: 7562472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of ligand choice on the apparent binding profile of gallamine to cardiac muscarinic receptors. Identification of three main types of gallamine-muscarinic receptor interactions.
    Lee NH; el-Fakahany EE
    J Pharmacol Exp Ther; 1988 Sep; 246(3):829-38. PubMed ID: 3418516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetrahydroaminoacridine and other allosteric antagonists of hippocampal M1 muscarine receptors.
    Potter LT; Ferrendelli CA; Hanchett HE; Hollifield MA; Lorenzi MV
    Mol Pharmacol; 1989 May; 35(5):652-60. PubMed ID: 2725474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three allosteric modulators act at a common site, distinct from that of competitive antagonists, at muscarinic acetylcholine M2 receptors.
    Lanzafame A; Christopoulos A; Mitchelson F
    J Pharmacol Exp Ther; 1997 Jul; 282(1):278-85. PubMed ID: 9223565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
    Burke RE
    Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic discrimination between receptor heterogeneity and allosteric interaction: resultant analysis of gallamine and pirenzepine antagonism of muscarinic responses in rat trachea.
    Kenakin T; Boselli C
    J Pharmacol Exp Ther; 1989 Sep; 250(3):944-52. PubMed ID: 2778720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of chimeric muscarinic receptors to investigate epitopes involved in allosteric interactions.
    Ellis J; Seidenberg M; Brann MR
    Mol Pharmacol; 1993 Sep; 44(3):583-8. PubMed ID: 7690450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gallamine allosterically antagonizes muscarinic receptor-mediated inhibition of adenylate cyclase activity in the rat myocardium.
    Ehlert FJ
    J Pharmacol Exp Ther; 1988 Nov; 247(2):596-602. PubMed ID: 3183955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel multivalent ligand that bridges the allosteric and orthosteric binding sites of the M2 muscarinic receptor.
    Steinfeld T; Mammen M; Smith JA; Wilson RD; Jasper JR
    Mol Pharmacol; 2007 Aug; 72(2):291-302. PubMed ID: 17478612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the interaction of gallamine with muscarinic receptor subtypes.
    Michel AD; Delmendo RE; Lopez M; Whiting RL
    Eur J Pharmacol; 1990 Jul; 182(2):335-45. PubMed ID: 2397745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allosteric effect of gallamine on muscarinic cholinergic receptor binding: influence of guanine nucleotides and conformational state.
    Narayanan TK; Aronstam RS
    Neurochem Res; 1986 Oct; 11(10):1397-406. PubMed ID: 3785535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.